Skip To Main Content

Impact.Sanofi Accessibility Statement

1. Commitment

Sanofi is committed to providing digital solutions that are accessible to the widest possible audience, regardless of ability, disability, race, cultural background, gender, or technological requirements.

This accessibility statement applies to Sanofi Impact.

 

2. Conformance status 

The Web Content Accessibility Guidelines (WCAG) defines requirements for designers and developers to improve accessibility for people with disabilities. It defines three levels of conformance: Level A, Level AA, and Level AAA.

This website is partially conformant with WCAG 2.2 Level AA, due to the limitations described below.

 

3. Known limitations

Despite our best efforts to ensure the accessibility of this website, there may be some limitations. Below is a description of known limitations and potential solutions. 

Please contact us if you observe an issue not listed below.

  • Videos: Some videos do not include closed captions or audio descriptions. 
  • Touch Buttons: Some touch elements do not have sufficient dimensions or spaces.
  • ARIA Roles: We're still in the early days of using ARIA roles, and we understand that some areas of the site may not yet have full accessibility support.

 

4. Feedback and contact 

Please contact us if you encounter accessibility barriers on this website. If you are unable to access any content or service, we will provide an accessible alternative or offer the content in another form.

 

5. Preparation of this accessibility statement

This statement was prepared on Feb 1st, 2026.

To evaluate the current level of accessibility, this website was assessed using automated web accessibility testing tools from Deque Systems. Comprehensive accessibility auditing will be completed in 2026.

 

6. Formal complaints

If you are not satisfied with our response to you, you are entitled to escalate a complaint to the national authority in France.